Northwire Canada EditionFriday, July 10, 2026
Northwire
TLO 5.37 +5.7% BNKR 4.88 +1.7% GG 2.25 +3.2% MJS 0.100 +5.3% PAAS 62.54 +3.6% PE 0.230 +0.0% SGML 17.19 +4.8% LAR 10.34 −1.1% NED 0.025 +0.0% GEN 0.080 +0.0% TVI 0.060 +0.0% SKYG 0.025 −37.5% WRLG 0.660 +6.5% FFU 0.120 −7.7% LOD 0.310 +3.3% CBI 0.110 +0.0% TLO 5.37 +5.7% BNKR 4.88 +1.7% GG 2.25 +3.2% MJS 0.100 +5.3% PAAS 62.54 +3.6% PE 0.230 +0.0% SGML 17.19 +4.8% LAR 10.34 −1.1% NED 0.025 +0.0% GEN 0.080 +0.0% TVI 0.060 +0.0% SKYG 0.025 −37.5% WRLG 0.660 +6.5% FFU 0.120 −7.7% LOD 0.310 +3.3% CBI 0.110 +0.0%
Technical Study Routine +

Euro Manganese Announces Positive Preliminary Economic Assessment

Euro Manganese PEA Validates Project Economics But Capital Gap Looms

Executive Summary
  • Event: Euro Manganese announced a Preliminary Economic Assessment (PEA) for its Chvaletice Manganese Project in the Czech Republic on May 14, 2026.
  • Economic Metrics: The PEA shows a post-tax NPV of $492M and a post-tax IRR of 13.8% at an 8% discount rate. Pre-tax NPV is $740M with a pre-tax IRR of 16.0%.
  • Production Profile: Targeting 150,000 tonnes per annum (tpa) of High-Purity Manganese Sulphate Monohydrate (HPMSM). Phase I capacity is 75,000 tpa, expanding to 150,000 tpa in Phase II.
  • Capital Requirements: Total estimated capital expenditure is $964.4M ($627.5M for Phase I, $197.8M for Phase II).
  • By-Product Revenue: Includes up to 20,000 tpa of Magnesium Carbonate (MgCO3) as a valuable by-product.
  • Timeline: Targeted start of production is 2032, indicating a long development horizon.
  • Process Validation: The PEA incorporates optimized metallurgical recoveries validated during the Demonstration Plant operations reported in October 2025.
Material Impact
  • Validation vs. Dilution Risk: While the PEA confirms project viability with strong margins (48%) and NPV, the total CAPEX of $964M is massive relative to the company's current market capitalization (~$17M). This implies a significant future equity raise or debt financing requirement that will likely result in substantial shareholder dilution.
  • Timeline Concerns: The 2032 start date for production means investors face a long wait for cash flows, increasing exposure to commodity price volatility and execution risk over the next six years.
  • Financing Context: Following the $11.2M financing in May 2025 (which included Eric Sprott and EBRD), this PEA provides the necessary economic case to pursue larger funding rounds, but does not solve the immediate capital gap.
  • Market Expectations: This news follows the Demonstration Plant validation (Oct 2025) and Optimization Program (May 2025). As a standard milestone in project development, it is largely expected by the market rather than being an unexpected surprise.
  • Price Sensitivity: The stock has already corrected significantly from its January 2026 high ($0.41) to current levels ($0.12), suggesting the market may have priced in the capital intensity risk prior to this announcement.
EMN · Price
Company Overview
  • Company: Euro Manganese Inc. (TSXV: EMN / ASX: EMN).
  • Flagship Project: Chvaletice Manganese Project in the Czech Republic.
  • Project Status: Advanced exploration/demonstration phase; PEA completed May 2026.
  • Product Focus: High-Purity Manganese Sulphate Monohydrate (HPMSM) and High Purity Manganese Metal (HPEMM).
  • Strategic Positioning: Positioned as Europe's only near-term source of low-carbon, traceable high-purity manganese for battery supply chains.
Read the original news release →

More from Euro Manganese Inc.